Featured Research

from universities, journals, and other organizations

Aspirin Treatment Failure Warning

Date:
August 14, 2005
Source:
Research Australia
Summary:
Treatment failures occur with any drug and aspirin is no exception. Evidence is growing that some people will not respond to the anti-coagulant action of aspirin and the drug will not protect against cardiovascular events despite its regular intake.

Treatment failures occur with any drug and aspirin is no exception.Evidence is growing that some people will not respond to theanti-coagulant action of aspirin and the drug will not protect againstcardiovascular events despite its regular intake.

Related Articles


Professor Andrew Szczeklik from Poland and Professor Graeme Hankeyfrom Western Australia will present the latest findings on aspirinresistance at the XXth Congress of the International Society ofThrombosis and Haemostasis today.

"There are at least two possible explanations for theaspirin-resistance phenomenon," said Professor Szczeklik. "One is highlevels of blood cholesterol, which can in itself promote coagulationevents in the blood stream. In patients with high cholesterol levels,aspirin in in normal doses has hardly any anti-clotting effects,whereas treatment with a statin (inhibitor of cholesterol)significantly reduces blood clotting. In patients with coronary heartdisease, aspirin exerts it anti-coagulant effects only when bloodcholesterol is in the 'normal' range."

Szczeklik went onto say, "A patients genetic make-up may altertheir response to aspirin resistance.. For example, in coronary heartdisease patients carrying one particular gene are resistant to theanti-coagulant action of aspirin and are at increased risk of an acutecoronary event."

Perth researcher, Professor Graeme Hankey, has shown thatpatients who show evidence of aspirin resistance do respond well toanother drug called Clopidogrel.

"Clopidogrel had anti-clotting and anti-inflammatory effectsin patients with diseased arteries. These effects were greatest in theaspirin-resistant patients," said Hankey.

"The use of aspirin has risen dramatically in Australia in thelate 1990's. This is why it is vital that aspirin resistance isconsidered when implementing anti-clotting therapy. Present dataindicate that this particularly applies to survivors of a heart attackor unstable angina, patients receiving bypass surgery as well as peoplewith high cholesterol," reported Hankey.


Story Source:

The above story is based on materials provided by Research Australia. Note: Materials may be edited for content and length.


Cite This Page:

Research Australia. "Aspirin Treatment Failure Warning." ScienceDaily. ScienceDaily, 14 August 2005. <www.sciencedaily.com/releases/2005/08/050811104703.htm>.
Research Australia. (2005, August 14). Aspirin Treatment Failure Warning. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2005/08/050811104703.htm
Research Australia. "Aspirin Treatment Failure Warning." ScienceDaily. www.sciencedaily.com/releases/2005/08/050811104703.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins